Associate Professor, USC Marshall School of Business
Professor Bristow is an expert on corporate finance and corporate governance, particularly in the areas of private equity and director education. Dr. Bristow spent 10 years in finance and marketing in the Pharmaceutical, Medical Device, and Diagnostics Divisions and in Corporate Finance with Eli Lilly & Company. In the 20 years since returning to academia, he has been a director and advisor. In 1999, he founded the Director Training and Certification Program, the first corporate governance educational program in the US using entrance and exit examinations. His academic interests concern the financing, governance, regulation and valuation of high growth firms. He has published papers in economics, engineering, and law journals, and has advised on matters involving corporate governance and director education since 1998. His research and teaching has received support from the National Institutes of Health, the NASDAQ, the four largest international audit firms, and a dozen national law firms. He began teaching finance at the University of Southern California in 2006. He won the prestigious Golden Apple Teaching Award in 2009 and the Premier Professor award in 2013, Dr. Bristow incorporates current events from the Wall Street Journal into his lectures making what happens in the economy and business world accessible to any dedicated student.
Dr. Bristow has been on both sides of hostile proxy matters and provided expert witness support on governance issues: twice he was an Oracle nominee for the PeopleSoft board. Lions Gate Films nominated him for the Image Entertainment Board. He was an Express Scripts nominee in the Caremark/CVS matter and a Community Health Systems nominee for the Tenet Board. He has chaired or served on all of the primary board committees – audit, compensation, nominating and governance, and three special committees involving anti-takeover defenses, investigations and technology strategy. He is an audit committee financial expert and frequent speaker at the KPMG Audit Committee Institute meetings. Dr. Bristow has been a director of Landec Corporation (Nasdaq: LNDC) and Arena Pharmaceuticals since September 2004 and was governance advisor to the board of Pacific Capital Bancorp. He was sole inventor for a medical device in June 2010 "Method for reducing the number of unwanted molecules in blood," and was awarded a medical device patent, United States Patent 7744883. It has since been issued in Canada and Japan. He has twice been selected to the Directorship 100 as of the most influential people in corporate governance by the National Association of Corporate Directors. Dr. Bristow is the Faculty Director of the USC Corporate Governance Summit.
A Midwesterner by birth, Duke received his BS in Chemical Engineering from Purdue University, his MBA from Indiana University and a Ph.D. in Financial Economics from UCLA.